| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 327 |
| 1 | PREDNISONE | 261 |
| 2 | DOXORUBICIN | 246 |
| 3 | CYCLOPHOSPHAMIDE | 231 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 231 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 231 |
| 6 | ETOPOSIDE | 95 |
| 7 | DEXAMETHASONE | 86 |
| 8 | DEXAMETHASONE 1.5 MG | 86 |
| 9 | CYTARABINE | 72 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARMUSTINE | 24 | 0.0051 |
| 1 | BENDAMUSTINE HCL | 70 | 0.0045 |
| 2 | IBRITUMOMAB TIUXETAN | 6 | 0.0039 |
| 3 | FLUDEOXYGLUCOSE F-18 | 1 | 0.0035 |
| 4 | AXICABTAGENE CILOLEUCEL | 29 | 0.0029 |
| 5 | TOLCAPONE | 1 | 0.0028 |
| 6 | DOXORUBICIN | 246 | 0.0027 |
| 7 | MOSUNETUZUMAB | 3 | 0.0027 |
| 8 | ETOPOSIDE PHOSPHATE | 4 | 0.0024 |
| 9 | GRANULOCYTE COLONY STIMULATING FACTOR | 5 | 0.0023 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 29 | 0.0029 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 7 | 0.0017 |
| 2 | Topoisomerase Inhibitor [EPC] | 94 | 0.0012 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 329 | 0.0010 |
| 4 | Alkylating Drug [EPC] | 243 | 0.0010 |
| 5 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 6 | Radioactive Diagnostic Agent [EPC] | 1 | 0.0003 |
| 7 | Platinum-based Drug [EPC] | 84 | 0.0003 |
| 8 | Corticosteroid [EPC] | 355 | 0.0003 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 72 | 0.0003 |